Success Metrics

Active Trials
2(33%)

Phase Distribution

Ph not_applicable
4
67%
Ph phase_1
1
17%
Ph phase_4
1
17%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
4(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(5)
Other(1)

Detailed Status

Not yet recruiting3
Recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 11 (16.7%)
Phase 41 (16.7%)
N/A4 (66.7%)

Trials by Status

not_yet_recruiting350%
recruiting233%
unknown117%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
6